Bayer have announced that Professor Dominik Ruettinger will be its new Head of Research and Early Development for Oncology, effective 1 October 2021.
List view / Grid view
7 March 2012 | By Amgen
Micromet will be the surviving corporation in the merger and will become a wholly owned subsidiary of Amgen...
2 March 2012 | By Amgen
Tender offer to acquire all outstanding shares of Micromet, Inc. - satisfied...
Amgen and Micromet announce early termination of HSR waiting period for Amgen’s acquisition of Micromet
15 February 2012 | By Amgen
Amgen and Micromet entered into a Merger Agreement...